|
106
|
390
|
3lpkA |
Structure of bace bound to sch747123 |
|
22
|
116
|
3liqA |
Crystal structure of htlv protease complexed with the inhibitor, kni-10673 |
|
21
|
116
|
3lixA |
Crystal structure of htlv protease complexed with the inhibitor kni-10729 |
|
24
|
116
|
3livA |
Crystal structure of htlv protease complexed with the inhibitor kni-10683 |
|
105
|
390
|
3l5fA |
Structure of bace bound to sch736201 |
|
100
|
386
|
3l38A |
Bace1 in complex with the aminopyridine compound 44 |
|
89
|
387
|
3kyrA |
Bace-1 in complex with a norstatine type inhibitor |
|
102
|
390
|
3l5cA |
Structure of bace bound to sch723871 |
|
98
|
387
|
3l3aA |
Bace-1 with the aminopyridine compound 32 |
|
103
|
390
|
3l5dA |
Structure of bace bound to sch723873 |
|
104
|
390
|
3l59A |
Structure of bace bound to sch710413 |
|
107
|
390
|
3l5eA |
Structure of bace bound to sch736062 |
|
104
|
395
|
3l58A |
Structure of bace bound to sch589432 |
|
103
|
390
|
3l5bA |
Structure of bace bound to sch713601 |
|
17
|
99
|
3kfpA |
Hiv protease (pr) with inhibitor tl-3 bound, and dmsos in exo site |
|
16
|
99
|
3kfnA |
Hiv protease (pr) with inhibitor tl-3 and fragment hit 4d9 by soaking |
|
104
|
395
|
3kmyA |
Structure of bace bound to sch12472 |
|
15
|
99
|
3kdbA |
Crystal structure of hiv-1 protease (q7k, l33i, l63i) in complex with kni-10006 |
|
43
|
203
|
3kt5A |
Crystal structure of n88s mutant hiv-1 protease |
|
87
|
337
|
3km4A |
Optimization of orally bioavailable alkyl amine renin inhibitors |
|
15
|
99
|
3kf0A |
Hiv protease with fragment 4d9 bound |
|
104
|
390
|
3kn0A |
Structure of bace bound to sch708236 |
|
15
|
99
|
3kdcA |
Crystal structure of hiv-1 protease (q7k, l33i, l63i) in complex with kni-10074 |
|
46
|
203
|
3kt2A |
Crystal structure of n88d mutant hiv-1 protease |
|
17
|
99
|
3kddA |
Crystal structure of hiv-1 protease (q7k, l33i, l63i) in complex with kni-10265 |
|
104
|
395
|
3kmxA |
Structure of bace bound to sch346572 |
|
17
|
99
|
3kfsA |
Hiv protease (pr) dimer with inhibitor tl-3 bound and fragment 2f4 in the outside/top of flap |
|
43
|
203
|
3ka2A |
Crystal structure of chemically synthesized 203 amino acid 'covalent dimer' [l-ala;gly51']hiv-1 protease molecule complexed with mvt-101 reduced isostere inhibitor at 1.4 a resolution |
|
18
|
99
|
3kfrA |
Hiv protease (pr) dimer with inhibitor tl-3 bound and fragment 1f1 in the outside/top of flap |
|
18
|
99
|
3k4vC |
New crystal form of hiv-1 protease/saquinavir structure reveals carbamylation of n-terminal proline |
|
17
|
99
|
3k4vA |
New crystal form of hiv-1 protease/saquinavir structure reveals carbamylation of n-terminal proline |
|
16
|
99
|
3jw2A |
Hiv-1 protease mutant g86s with darunavir |
|
98
|
388
|
3k5gA |
Human bace-1 complex with bjc060 |
|
97
|
388
|
3k5cA |
Human bace-1 complex with nb-216 |
|
20
|
99
|
3jvyA |
Hiv-1 protease mutant g86a with darunavir |
|
92
|
388
|
3k5dA |
Crystal structure of bace-1 in complex with ahm178 |
|
91
|
338
|
3k1wA |
New classes of potent and bioavailable human renin inhibitors |
|
93
|
388
|
3k5fA |
Human bace-1 complex with ayh011 |
|
19
|
99
|
3jvwA |
Hiv-1 protease mutant g86a with symmetric inhibitor dmp323 |
|
103
|
387
|
3in4A |
Bace1 with compound 38 |
|
103
|
387
|
3in3A |
Bace1 with compound 30 |
|
101
|
389
|
3iviA |
Design and synthesis of potent bace-1 inhibitors with cellular activity: structure-activity relationship of p1 substituents |
|
103
|
389
|
3infA |
Bace1 with the aminohydantoin compound 37 |
|
105
|
389
|
3ivhA |
Design and synthesis of potent bace-1 inhibitors with cellular activity: structure-activity relationship of p1 substituents |
|
100
|
389
|
3inhA |
Bace1 with the aminohydantoin compound r-58 |
|
96
|
389
|
3indA |
Bace1 with the aminohydantoin compound 29 |
|
94
|
388
|
3ixkA |
Potent beta-secretase 1 inhibitor |
|
100
|
388
|
3ineA |
Bace1 with the aminohydantoin compound s-34 |
|
93
|
388
|
3ixjA |
Crystal structure of beta-secretase 1 in complex with selective beta-secretase 1 inhibitor |
|
18
|
99
|
3ixoA |
Crystal structure of uncomplexed hiv_1 protease subtype a |